Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-01-16 @ 10:43 AM
Study NCT ID:
NCT02629692
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-31
First Post:
2015-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies
Sponsor:
Sun Pharma Advanced Research Company Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-10
First Submit QC Date:
None
Study First Post Date:
2015-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-07-31
Last Update Post Date Type:
ACTUAL